Ligand validation:6LF7

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 6LF7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LF7_EDO_A_613	55%	79%	0.15	0.918	0.69	0.19	-	-	1	0	100%	1
6LF7_EDO_A_611	54%	90%	0.147	0.91	0.24	0.35	-	-	0	0	100%	1
6LF7_EDO_A_637	49%	78%	0.151	0.899	0.22	0.65	-	-	2	0	100%	1
6LF7_EDO_A_612	48%	86%	0.122	0.862	0.36	0.35	-	-	2	0	100%	1
7DLQ_EDO_A_615	97%	29%	0.063	0.978	1.9	0.97	2	-	1	0	100%	1
4GM7_EDO_A_620	46%	40%	0.173	0.909	1.59	0.78	1	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.44	0.35	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.